Medtronic (BUE:MDT) Cyclically Adjusted Book per Share: ARS16,793.78 (As of Apr. 2026)


BUE:MDT Medtronic PLC BUE:MDT
66 GF Score
Price ARS32,660.00
GF Value ARS37,930.04
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cyclically Adjusted Book per Share?

Medtronic BUE:MDT -1.80% 66 Cyclically Adjusted Book per Share is ARS16,793.78 as of Apr. 2026. GuruFocus rates BUE:MDT with a GF Score™ of 66/100 and a GF Value™ of ARS37,930.04 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medtronic's adjusted book value per share for the three months ended in Apr. 2026 was ARS107,489.412. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ARS16,793.78 for the trailing ten years ended in Apr. 2026.

During the past 12 months, Medtronic's average Cyclically Adjusted Book Growth Rate was -0.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 7.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Medtronic was 22.80% per year. The lowest was 3.60% per year. And the median was 12.30% per year.

As of today (2026-07-07), Medtronic's current stock price is ARS32660.00. Medtronic's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2026 was ARS16,793.78. Medtronic's Cyclically Adjusted PB Ratio of today is 1.94.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medtronic was 5.15. The lowest was 1.68. And the median was 3.51.


Medtronic  (BUE:MDT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medtronic's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=32660.00/16793.78
=1.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medtronic was 5.15. The lowest was 1.68. And the median was 3.51.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medtronic Cyclically Adjusted Book per Share Related Terms


Medtronic Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Medtronic's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cyclically Adjusted Book per Share Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,820.76 4,482.96 11,524.83 13,143.54 16,793.78

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,143.54 14,939.19 16,673.51 16,372.99 16,793.78

BUE:MDT vs SYK, BSX, EW: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted PB Ratio falls into.


BUE:MDT
66GF Score
Medtronic PLC BUE:MDT
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medtronic's adjusted Book Value per Share data for the three months ended in Apr. 2026 was:

Adj_Book= Book Value per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=107489.412/128.4300*128.4300
=107,489.412

Current CPI (Apr. 2026) = 128.4300.

Medtronic Quarterly Data

Book Value per Share CPI Adj_Book
201607 1,105.344 100.872 1,407.319
201610 1,105.261 99.776 1,422.678
201701 1,150.140 99.178 1,489.372
201704 1,129.275 100.773 1,439.210
201707 1,327.991 100.673 1,694.141
201710 1,345.290 100.374 1,721.322
201801 1,454.950 99.377 1,880.307
201804 1,506.299 100.374 1,927.335
201807 2,146.096 101.470 2,716.296
201810 3,042.279 101.271 3,858.165
201901 2,796.477 100.075 3,588.831
201904 3,234.044 102.068 4,069.317
201907 3,190.438 101.969 4,018.374
201910 4,346.148 101.969 5,473.997
202001 4,625.983 101.371 5,860.827
202004 4,877.444 101.969 6,143.167
202007 5,280.017 101.570 6,676.314
202010 5,684.678 100.474 7,266.425
202101 6,334.438 101.171 8,041.141
202104 7,017.968 103.065 8,745.138
202107 7,333.089 103.763 9,076.361
202110 7,636.696 105.557 9,291.490
202201 8,036.868 106.255 9,714.158
202204 8,776.244 110.242 10,224.198
202207 9,937.844 113.262 11,268.696
202210 11,491.116 115.315 12,798.034
202301 13,676.256 114.470 15,344.161
202304 13,682.959 118.213 14,865.572
202307 19,748.084 119.903 21,152.415
202310 27,080.667 121.111 28,717.234
202401 62,980.657 119.179 67,869.445
202404 65,670.333 121.232 69,569.657
202407 68,266.376 122.560 71,536.046
202410 73,352.360 121.956 77,246.186
202501 80,914.772 121.473 85,548.851
202504 87,286.894 123.888 90,486.946
202507 98,635.728 124.613 101,657.349
202510 109,259.269 125.410 111,890.343
202601 110,237.969 124.690 113,544.489
202604 107,489.412 128.430 107,489.412

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ARS16,793.78 mean?
Medtronic (BUE:MDT) has a Cyclically Adjusted Book per Share of ARS16,793.78 as of Apr. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medtronic and its competitors.
Is Medtronic's Cyclically Adjusted Book per Share too high?
Medtronic's current Cyclically Adjusted Book per Share is ARS16,793.78. Overall, Medtronic has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Cyclically Adjusted Book per Share compare to SYK and BSX?
Medtronic's Cyclically Adjusted Book per Share of ARS16,793.78 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medtronic and its competitors. Medtronic's current Cyclically Adjusted Book per Share is ARS16,793.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BUE:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is ARS37,930.04, compared to a current price of ARS32,660.00 — trading 13.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is ARS16,793.78. Medtronic's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Medtronic (BUE:MDT), the current Cyclically Adjusted Book per Share is ARS16,793.78 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BUE:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of ARS32,660.00 is trading 13.9% below its estimated GF Value™ of ARS37,930.04. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BUE:MDT:

  • Cyclically Adjusted Book per Share: ARS16,793.78
  • GF Value™: ARS37,930.04 vs. price of ARS32,660.00 (13.9% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the BUE:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
66GF Score

Get the complete analysis for BUE:MDT

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS32,660.00
Price
ARS37,930.04
GF Value